Theravance Biopharma to Report Second Quarter 2024 Financial Results on August 5, 2024
Theravance Biopharma (NASDAQ: TBPH) has announced that it will release its second quarter 2024 financial results after market close on August 5, 2024. The company will also provide a business update during this report. Following the release, Theravance Biopharma will host a conference call and simultaneous webcast at 5:00 pm ET (2:00 pm PT/10:00 pm IST) on the same day.
Interested parties can pre-register for the telephone conference call or access the live webcast through the Investors section of Theravance Biopharma's website. A replay of the webcast will be available on the company's website for 30 days, until September 4, 2024.
Theravance Biopharma (NASDAQ: TBPH) ha annunciato che pubblicherà i suoi risultati finanziari del secondo trimestre 2024 dopo la chiusura del mercato il 5 agosto 2024. L'azienda fornirà anche un aggiornamento sulle attività durante questo rapporto. Dopo la pubblicazione, Theravance Biopharma ospiterà una telefonata di conferenza e una diretta streaming alle 17:00 ET (14:00 PT/22:00 IST) lo stesso giorno.
Le parti interessate possono preregistrarsi per la telefonata di conferenza o accedere alla diretta streaming tramite la sezione Investitori del sito web di Theravance Biopharma. Una registrazione della diretta sarà disponibile sul sito dell'azienda per 30 giorni, fino al 4 settembre 2024.
Theravance Biopharma (NASDAQ: TBPH) ha anunciado que publicará sus resultados financieros del segundo trimestre de 2024 después del cierre del mercado el 5 de agosto de 2024. La empresa también proporcionará una actualización de negocios durante este informe. Tras la publicación, Theravance Biopharma llevará a cabo una conferencia telefónica y una transmisión simultánea a las 5:00 p.m. ET (2:00 p.m. PT/10:00 p.m. IST) el mismo día.
Las partes interesadas pueden preinscribirse para la conferencia telefónica o acceder a la transmisión en vivo a través de la sección de Inversores del sitio web de Theravance Biopharma. Se dispondrá de una repetición de la transmisión en el sitio web de la compañía durante 30 días, hasta el 4 de septiembre de 2024.
Theravance Biopharma (NASDAQ: TBPH)는 2024년 2분기 재무 결과를 2024년 8월 5일 시장 종료 후 발표할 것이라고 발표했습니다. 회사는 이 보고서에서 비즈니스 업데이트도 제공할 예정입니다. 발표 후, Theravance Biopharma는 같은 날 동부 표준시 오후 5:00 (태평양 표준시 오후 2:00/IST 밤 10:00)에 전화 회의 및 동시 웹캐스트를 개최합니다.
관심 있는 분들은 Theravance Biopharma 웹사이트 투자자 섹션을 통해 전화 회의에 사전 등록하거나 생중계에 접속할 수 있습니다. 생중계의 다시보기는 회사 웹사이트에서 30일 동안, 즉 2024년 9월 4일 까지 이용할 수 있습니다.
Theravance Biopharma (NASDAQ: TBPH) a annoncé qu'elle publiera ses résultats financiers du deuxième trimestre 2024 après la clôture du marché le 5 août 2024. L'entreprise fournira également une mise à jour sur ses activités lors de ce rapport. Suite à la publication, Theravance Biopharma organisera un appel de conférence et un webinaire en direct à 17h00 ET (14h00 PT/22h00 IST) le même jour.
Les parties intéressées peuvent se préinscrire à l'appel téléphonique de conférence ou accéder au webinaire en direct via la section Investisseurs du site Web de Theravance Biopharma. Un enregistrement du webinaire sera disponible sur le site de l'entreprise pendant 30 jours, jusqu'au 4 septembre 2024.
Theravance Biopharma (NASDAQ: TBPH) hat bekannt gegeben, dass die Finanzergebnisse für das zweite Quartal 2024 nach Marktschluss am 5. August 2024 veröffentlicht werden. Das Unternehmen wird in diesem Bericht auch ein Unternehmensupdate bereitstellen. Nach der Veröffentlichung wird Theravance Biopharma am selben Tag um 17:00 Uhr ET (14:00 Uhr PT/22:00 Uhr IST) eine Telefonkonferenz und einen gleichzeitigen Webcast veranstalten.
Interessierte Parteien können sich für die Telefonkonferenz vorregistrieren oder über den Investorenbereich der Website von Theravance Biopharma auf den Live-Webcast zugreifen. Eine Aufzeichnung des Webcasts wird für 30 Tage auf der Unternehmenswebsite verfügbar sein, bis zum 4. September 2024.
- None.
- None.
Conference Call Information
To participate in the live call by telephone, please pre-register here. Those interested in listening to the conference call live via the internet may do so by visiting Theravance Biopharma's website at www.theravance.com, under the Investors section, Events and Presentations.
A replay of the webcast will be available on Theravance Biopharma's website for 30 days through September 4, 2024.
About Theravance Biopharma
Theravance Biopharma, Inc.'s focus is to deliver Medicines that Make a Difference® in people's lives. In pursuit of its purpose, Theravance Biopharma leverages decades of expertise, which has led to the development of FDA-approved YUPELRI® (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). Ampreloxetine, its late-stage investigational once-daily norepinephrine reuptake inhibitor in development for symptomatic neurogenic orthostatic hypotension (nOH) in patients with Multiple System Atrophy (MSA), has the potential to be a first in class therapy effective in treating a constellation of cardinal symptoms in MSA patients. The Company is committed to creating/driving shareholder value.
For more information, please visit www.theravance.com.
THERAVANCE BIOPHARMA®, THERAVANCE® and the Cross/Star logo are registered trademarks of the Theravance Biopharma group of companies (in the U.S. and certain other countries).
YUPELRI® is a registered trademark of Mylan Specialty L.P., a Viatris company. Trademarks, trade names or service marks of other companies appearing in this press release are the property of their respective owners.
Contact:
investor.relations@theravance.com
650-808-4045
View original content to download multimedia:https://www.prnewswire.com/news-releases/theravance-biopharma-to-report-second-quarter-2024-financial-results-on-august-5-2024-302202418.html
SOURCE Theravance Biopharma, Inc.
FAQ
When will Theravance Biopharma (TBPH) report its Q2 2024 financial results?
What time is Theravance Biopharma's (TBPH) Q2 2024 earnings conference call?
How can I access Theravance Biopharma's (TBPH) Q2 2024 earnings call?
How long will the replay of Theravance Biopharma's (TBPH) Q2 2024 earnings call be available?
